Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PKM2 |
| Upstream (Parents) |
|---|
| (<<) ALDOA → PKM2 |
| (<<) ANXA2 → PKM2 |
| (<<) BDH1 → PKM2 |
| (<<) CBS → PKM2 |
| (<<) CYP4F2 → PKM2 |
| (<<) ELF4 → PKM2 |
| (<<) MAFF → PKM2 |
| (<<) MTHFD2 → PKM2 |
| (<<) RBKS → PKM2 |
| (<<) SAA4 → PKM2 |
| (<<) SET → PKM2 |
| (<<) SMURF2 → PKM2 |
| (<<) TUBA1B → PKM2 |
| (<<) TUBA1C → PKM2 |
| Downstream (Children) |
|---|
| PKM2 → ACTG1 (>>) |
| PKM2 → CCNB1 (>>) |
| PKM2 → CDCP1 (>>) |
| PKM2 → CDH3 (>>) |
| PKM2 → CSNK1D (>>) |
| PKM2 → EFHD2 (>>) |
| PKM2 → EFNB2 (>>) |
| PKM2 → EGFR (>>) |
| PKM2 → ENO2 (>>) |
| PKM2 → GAPDH (>>) |
| PKM2 → HK1 (>>) |
| PKM2 → HK2 (>>) |
| PKM2 → IL23A (>>) |
| PKM2 → ITGB4 (>>) |
| PKM2 → JUND (>>) |
| PKM2 → KIAA1199 (>>) |
| PKM2 → MAT2A (>>) |
| PKM2 → MMP12 (>>) |
| PKM2 → PHLDA1 (>>) |
| PKM2 → PHLDA2 (>>) |
| PKM2 → PLAUR (>>) |
| PKM2 → PLK3 (>>) |
| PKM2 → SFN (>>) |
| PKM2 → SMTN (>>) |
| PKM2 → STX1A (>>) |
| PKM2 → TMSB10 (>>) |
| PKM2 → TPM4 (>>) |
| PKM2 → TSPAN3 (>>) |
| PKM2 → TSPO (>>) |
| PKM2 → VPS37B (>>) |
